Retrospective Evaluation of Ketamine Effectiveness for the Treatment of Acute Battlefield Related Pain

NCT04057989 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2019-08-15

No results posted yet for this study

Summary

Using a retrospective review of records, we will conduct a multivariate analysis to examine the relationship between exposure to ketamine, as an analgesic agent in combat related trauma care, the use of additional opioid pain medications, and patient reported pain levels.

Conditions

  • Pain, Acute
  • Analgesia
  • Amputation, Traumatic
  • Post Traumatic Stress Disorder
  • Trauma, Brain

Interventions

DRUG

ketamine

Sponsors & Collaborators

  • Defense and Veterans Center for Integrative Pain Management

    lead OTHER

Principal Investigators

  • Michael Kent, MD · Walter Reed National Military Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2017-08-31
Completion
2017-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04057989 on ClinicalTrials.gov